Candriam S.C.A. Amarin Corp Plcuk Transaction History

Candriam S.C.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 22, 2021	SELL	$4.04 - $5.31 $2.45 Million - $3.22 Million	-606,000 Closed	0 $0
Q2 2020 Jul 23, 2020	SELL	$4.78 - $8.26 $119,500 - $206,500	-25,000 Reduced 3.96%	606,000 $4.19 Million
Q4 2019 Jan 21, 2020	BUY	$13.94 - $24.12 $153,340 - $265,320	11,000 Added 1.77%	631,000 $14,000
Q3 2019 Oct 21, 2019	BUY	$13.89 - $23.16 $8.61 Million - $14.4 Million	620,000 New	620,000 $9,000

178

65.3M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $210M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.